Organigram Global (OGI) Stock Statistics & Valuation Metrics

Organigram Global has a market cap or net worth of $124.88M. The enterprise value is $217.07M.

Market Cap

$124.88M

Enterprise Value

$217.07M

Organigram Global has 141,006,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

141,006,500

Owned by Insiders

35.11%

Owned by Institutions

3.53%

Organigram Global’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -12.98%.

Return on Equity (ROE)

-0.07

Return on Assets (ROA)

-0.04

Return on Invested Capital (ROIC)

-12.98%

Return on Capital Employed (ROCE)

-0.20

Revenue Per Employee

227.55K

Profits Per Employee

-21.74K

Employee Count

1,139

Asset Turnover

0.46

Inventory Turnover

2.01

The current PE Ratio of Organigram Global is 1.93. Organigram Global’s PEG ratio is 0.00.

PE Ratio

1.93

PS Ratio

0.57

PB Ratio

0.35

Price to FCF

-6.02

Price to Operating Cash Flow

-6.00

PEG Ratio

0.00

In the last 12 months, Organigram Global had revenue of 259.18M and earned -24.76M in profits. Earnings per share was -0.19.

Revenue

259.18M

Gross Profit

9.51M

Operating Income

-88.31M

Pretax Income

-38.53M

Net Income

-24.76M

EBITDA

-20.55M

Earnings Per Share (EPS)

-0.19

In the last 12 months, operating cash flow was -27.93M and capital expenditures -1.13M, giving a free cash flow of -29.06M billion.

Operating Cash Flow

-27.93M

Free Cash Flow

-29.06M

Free Cash Flow per Share

-0.22

Organigram Global pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-16.76%

Earnings Yield

52.12%

Beta

1.13

52-Week Price Change

-40.81%

50-Day Moving Average

1.01

200-Day Moving Average

1.18

Relative Strength Index (RSI)

36.10

Average Volume (3m)

948.28K

Organigram Global upcoming earnings date is Dec 22, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 11, 2026

Next Earnings Date

Dec 22, 2026

Ex-Dividend Date

―

Organigram Global as a current ratio of 2.26, with Debt / Equity ratio of 2.51%

Current Ratio

2.26

Quick Ratio

1.28

Debt to Market Cap

0.00

Net Debt to EBITDA

3.64

Interest Coverage Ratio

0.00

In the past 12 months, Organigram Global has paid -13.77M in taxes.

Income Tax

-13.77M

Effective Tax Rate

0.36

Organigram Global EV to EBITDA ratio is -6.91, with an EV/FCF ratio of -6.68.

EV to Sales

0.63

EV to EBITDA

-6.91

EV to Free Cash Flow

-6.68

EV to Operating Cash Flow

-6.95

Organigram Global has $11.67M in cash and marketable securities with $31.45M in debt, giving a net cash position of -$19.79M billion.

Cash & Marketable Securities

$11.67M

Total Debt

$31.45M

Net Cash

-$19.79M

Net Cash Per Share

-$0.14

Tangible Book Value Per Share

$0.65

Gross margin is 2.22%, with operating margin of -31.84%, and net profit margin of 28.02%.

Gross Margin

2.22%

Operating Margin

-31.84%

Pretax Margin

26.29%

Net Profit Margin

28.02%

EBITDA Margin

-9.08%

EBIT Margin

-19.14%

The average price target for Organigram Global is $2.24, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$2.24

Price Target Upside

155.38% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

39.67%

EPS Growth Forecast

3137.32%

Smart Score

7

AI Score

―